A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human immunodeficiency virus (HIV) infection but selects for NVP-resistant virus, which compromises subsequent NVP-based therapy. A 1-week "tail" of lamivudine and zidovudine after SD-NVP decreases...
Saved in:
相似書籍
-
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
由: Russell B. Van Dyke, et al.
出版: (2018) -
A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
由: Van Dyke R., et al.
出版: (2017) -
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Tim R. Cressey, et al.
出版: (2018) -
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Tim R. Cressey, et al.
出版: (2018) -
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine
由: Marc Lallemant, et al.
出版: (2018)